SeaStar Medical Holding Obtains FDA Approvable Letter for Selective Cytopheretic Device-Pediatric
SeaStar Medical Holding, a leading medical technology company, has announced a significant development in its proprietary Selective Cytopheretic Device (SCD) for pediatric patients. The U.S. Food and Drug Administration's Center…